Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to assess the antiviral efficacy of telaprevir, Peg-IFN-alfa-2a, and RBV in HCV-1/HIV-1 coinfected subjects as measured by sustained virologic response (SVR12planned). SVR12planned is defined as having HCV RNA levels < 25 IU/mL 12 weeks after the last planned dose of HCV study medication.
Critère d'inclusion
- Chronic Hepatitis C Infection